Difficulties in diagnosing tuberculosis in pregnancy
To the Editor: Diagnosing tub b berculosis (TB) in pregnancy can be difficult because of the vague, nonbspecific nature of the sympb b toms. Fatigue, shortness of breath, sweating and tired, all characteristic of TB, can also be due to pregnancy. Most physicians are reluctant to orb b der a chest xbray for fear of harming the fetus. This case illustrates the problems in early recognition and management of TB in pregnancy.
An 18bweek pregnant woman who had a lowbgrade fever for 3 months underwent an extensive and unnecessary work up for pyrexia of unknown etiology. All tests were normal including a bone marrow biopsy. Due to concerns over harmb b ing the fetus, a chest xbray was not performed. MRI of the chest and abdomen showed a miliary pattern. The diagnosis was tuberculosis (TB). A sputum culture was posib b tive for acidbfast bacilli and sensitive to firstbline antibTB therapy. A chest xbray requested 2 weeks after admisb b sion showed the miliary shadow. A PPD skin test was negative. The pab b tient received antibTB therapy for 9 months without complications. She had a baby girl who was healthy.
Treatment of TB in pregnancy is multidisciplinary, requiring inb b put from all physicians involved in the care of the mother and fetus. Between 20% and 67% of pregnant patients presenting with pulmonary TB are unaware of their disease and have no significant symptoms. 1 Available information suggests that pregnancy has little, if any, effect on the clinical course of TB.
2 Screening for TB in pregnancy is not required because of the reluctance to do a chest xbray on a pregnant women. A review of TB diagnoses in Rhode Island, USA from 1987 to 1991 found that pregnant women with TB were most likely to be identified through routine screening and to be asymptomatic. 1 If the chest xbray is necessary, suitable shielding will limit fetal radiation exposure to less than 0.3 mrads and should not harm the fetus. 3 The perception of teratob b genic risk is higher than the actual risk. 4 MRI uses electromagnetic radio waves, rather than ionizb b ing radiation, to generate detailed computer images. There are no reb b ported harmful effects from MRI on the pregnant woman or fetus. 5 However, MRI is not recommendb b ed in the first trimester since safety information during organogenesis is limited. A TB skin test using pub b rified protein derivative (PPD) is safe and accurate during pregnancy and is recommended for women who have TB symptoms or are at high risk for TB. It is as reliable as in nonbpregnant women. 6, 7 No evidence suggests that TB affects or complicates either the course of pregnancy or delivery; women with and without TB have similar rates of normal, spontaneous deliveries. 9 Combination antibTB therapy in pregnancy is safe and effective. Most experts consider the drugs of choice to be rifampin, combined with isob b niazid and ethambutol. 10 All these drugs cross the placenta and reach low concentrations in human feb b tal fluids and tissues, but there are no reports linking the use of these drugs with congenital anomalies. The following antibTB drugs are contraindicated in pregnant womb b en: streptomycin, kanamycin, amib b kacin, capreomycin and the fluorob b quinolones. Women on secondbline agents for multibdrug resistant TB need to be assessed on an individual basis regarding their risks. Women who become pregnant on antibTB therapy can be reassured that there is no increased risk to their baby, and they should complete their treatment course. 8b10 Breastfeeding should not be disb b couraged for women being treated with the firstbline antibTB drugs because the concentrations of these drugs in breast milk are too small to produce toxicity in the nursing newborn. 8 Congenital TB in neonates has morbidity and mortality approachb b ing 50%. 11 About 200 cases have been reported in the English literab b ture. 12, 13 The child can be infected in the uterus if the mother has had miliary TB, TB of the placenta or uterus, or has advanced HIV. 
